Fact CheckerSign in

NCT05211882Completed

ENABLE (Educate, Nurture, Advise, Before Life Ends) Intervention for Heart Failure (HF) Patients and Their Caregivers in Singapore

Pilot Wait-list Randomized Controlled Trial of the ENABLE (Educate, Nurture, Advise, Before Life Ends) Intervention for Heart Failure (HF) Patients and Their Caregivers in Singapore

Source: ClinicalTrials.gov · Last updated 3 Sept 2025

Brief summary (registry, in English)

To pilot a culturally adapted version of ENABLE (6-month program) for Heart Failure (HF) patients and caregivers in the inpatient and outpatient setting in Singapore. The investigators aim to determine the feasibility of trial procedures and assess the acceptability and preliminary efficacy of ENABLE with a randomized wait-list controlled trial design.

Status (registry)
Completed
Study type
Interventional
Enrollment
125 (actual)
First submitted
2 Jan 2022
Start date
14 Feb 2022
Primary completion date
25 Sept 2024
Lead sponsor
National Cancer Centre, Singapore
NCT number
NCT05211882

What you commit to

  • Study type: Interventional
  • Participants enrolled: 125
  • From 14 Feb 2022 to the primary completion date, 25 Sept 2024
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Exclusion criteria for patients:
    • Patients who are unable to give informed consent
    • Patients who are already known to a palliative care service.
  • Exclusion criteria for caregivers:
    • Caregivers who are unable to give informed consent.
    • Caregivers who are domestic helpers.

Who the study is looking for

  • Inclusion criteria for patients:
    • 21 years or older.
    • Able to communicate in English or Chinese.
    • Have a diagnosis of HF (stage C or D) by the American College of Cardiology guidelines and be of New York Heart Association (NYHA) stage 2, 3 or 4 functional statuses.
    • Have an expected prognosis of at least 6 months.
    • Be on disease directed HF management.
    • Have had a hospitalization event within 6 months prior to recruitment.
  • Inclusion criteria for caregivers:
    • 21 years or older.
    • Able to communicate in English or Chinese.
    • Is a direct family caregiver of the patient.

Age in the registry: 21 years to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Heart Centre Singapore
Coordinator of this site? Confirm its status
SingaporeSingaporeUnknown status
National Cancer Centre Singapore
Coordinator of this site? Confirm its status
SingaporeSingaporeUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.